TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmarelations AB
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
27,912
|
29,805
|
26,953 |
| Financial expenses |
36
|
39
|
31 |
| Earnings before taxes |
1,121
|
1,957
|
2,079 |
| EBITDA |
1,046
|
1,918
|
2,098 |
| Total assets |
10,692
|
10,851
|
8,825 |
| Current assets |
10,642
|
10,799
|
8,766 |
| Current liabilities |
3,321
|
4,184
|
3,309 |
| Equity capital |
6,911
|
6,231
|
4,724 |
| - share capital |
9
|
10
|
9 |
| Employees (average) |
204
|
227
|
197 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
64.6%
|
57.4%
|
53.5% |
| Turnover per employee |
137
|
131
|
137 |
| Profit as a percentage of turnover |
4.0%
|
6.6%
|
7.7% |
| Return on assets (ROA) |
10.8%
|
18.4%
|
23.9% |
| Current ratio |
320.4%
|
258.1%
|
264.9% |
| Return on equity (ROE) |
16.2%
|
31.4%
|
44.0% |
| Change turnover |
-879
|
2,773
|
8,383 |
| Change turnover % |
-3%
|
10%
|
45% |
| Chg. No. of employees |
-23
|
30
|
51 |
| Chg. No. of employees % |
-10%
|
15%
|
35% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.